Skip to main content
. 2021 Apr 9;8:636065. doi: 10.3389/fmed.2021.636065

Figure 1.

Figure 1

(A) Illustration of different possible dose-response relationships that can be fitted for continuous clinical indicators (e.g., age, fasting blood glucose, body mass index, etc.) to show the risk ratios of COVID-19 outcomes (e.g., hospitalization, ICU admission, or death). (B) A hypothesis on how FBG can affect COVID19 outcomes.